Argenica Therapeutics Ltd (AGN.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,555 | 15,913 | 9,289 | 8,914 | 7,144 |
| Marketable Securities | N/A | N/A | 50 | N/A | N/A |
| Receivables | 421 | 372 | 152 | 72 | 78 |
| TOTAL | $11,038 | $16,377 | $9,540 | $9,042 | $7,271 |
| Non-Current Assets | |||||
| Intangibles | 1 | 1 | 1 | 1 | 1 |
| TOTAL | $1 | $1 | $1 | $1 | $1 |
| Total Assets | $11,039 | $16,378 | $9,541 | $9,043 | $7,272 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,884 | 1,403 | 1,141 | 672 | 374 |
| TOTAL | $3,802 | $2,427 | $1,874 | $736 | $426 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 616 | 704 | 659 | N/A | N/A |
| TOTAL | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,802 | $2,427 | $1,874 | $736 | $426 |
| Shareholders' Equity | |||||
| Common Shares | 29,630 | 28,429 | 16,618 | 13,065 | 8,051 |
| Retained earnings | -22,733 | -15,686 | -10,319 | -5,504 | -1,413 |
| Other shareholders' equity | 341 | 1,208 | 1,367 | 746 | 209 |
| TOTAL | $7,237 | $13,951 | $7,666 | $8,307 | $6,847 |
| Total Liabilities And Equity | $11,039 | $16,378 | $9,541 | $9,043 | $7,272 |